Treatment of knee osteoarthritis with oral chondroitin sulfate (Q36713906)

15 August 2017

1 reference

title

Treatment of knee osteoarthritis with oral chondroitin sulfate (English)

1 reference

15 August 2017

1 reference

1 reference

Gust Verbruggen

1 reference

15 August 2017

Daniel Uebelhart

1 reference

15 August 2017

Ruud Knols

series ordinal

1 reference

15 August 2017

Eling D de Bruin

series ordinal

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

inferred from page(s)

published in

Advances in Pharmacology

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

523-539

1 reference

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Risk factors for the incidence and progression of radiographic knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Generalized estimating equations for multivariate response with the variates having different distributions.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Effects of self‐care education on the health status of inner‐city patients with osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Genetic influences on osteoarthritis in women: a twin study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

1 reference

7 January 2021

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2805%2953027-8

7 January 2021

10.1016/S1054-3589(05)53027-8

Identifiers

DOI

1 reference

release_rzztzczuingtzlmj52obwqbhbu

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rzztzczuingtzlmj52obwqbhbu

24 November 2022

mapped directly with Wikidata item

1 reference